Interleukin Genetics Inc (ILIU)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Interleukin Genetics Inc (ILIU) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010920
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Interleukin Genetics Inc (Interleukin) is a molecular diagnostics company which develops and distributes genetic tests for the personalized health market. Its major genetic tests include ILUSTRA genetic risk test ; cardiovascular risk test; weight management genetic test; bone health genetic test; heart health genetic test; nutritional needs genetic test; and wellness select genetic test. ILUSTRA genetic test analyzes genetic variations associated with inflammation and helps in identifying individuals who are at increased risk for severe periodontal disease. The company distributes its products through partnership with healthcare professionals, health and wellness companies, and distribution channels. Interleukin is headquartered in Waltham, Massachusetts, the US.

Interleukin Genetics Inc (ILIU) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Interleukin Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Interleukin Genetics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Interleukin Genetics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Interleukin Genetics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Interleukin Genetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Interleukin Genetics Inc, Medical Equipment, Deal Details 10
Partnerships 10
Interleukin Genetics Enters into Licensing Agreement with NYU School of Medicine 10
Interleukin Genetics Enters Into Research Collaboration With Metagenics 11
Access Business Group Enters into Licensing Agreement with Interleukin Genetics 12
Equity Offering 13
Interleukin Genetics Raises USD5.6 Million in Private Placement of Shares 13
Interleukin Genetics Raises USD5 Million in Private Placement of Shares and Warrants 15
Interleukin Genetics Completes Private Placement Of Shares And Warrants For US$12 Million 16
Interleukin Genetics Completes Private Placement Of Series B Convertible Preferred Stock For US$3 Million 17
Debt Offering 18
Interleukin Genetics Raises USD1 million in Issue of Subordinated Convertible Promissory Notes 18
Asset Transactions 19
Orig3N Acquires CLIA laboratory and Remaining Assets from Interleukin Genetics 19
Interleukin Genetics Inc – Key Competitors 20
Interleukin Genetics Inc – Key Employees 21
Interleukin Genetics Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Financial Announcements 23
May 12, 2017: Interleukin Genetics Reports First Quarter 2017 Financial Results 23
Apr 18, 2017: Interleukin Genetics Reports Fourth Quarter and Year-End 2016 Financial Results 25
Nov 15, 2016: Interleukin Genetics Reports Third Quarter 2016 Financial Results 27
Aug 16, 2016: Interleukin Genetics Reports Second Quarter 2016 Financial Results 29
May 16, 2016: Interleukin Genetics Reports First Quarter 2016 Financial Results 31
Mar 17, 2016: Interleukin Genetics Reports Fourth Quarter and Year-End 2015 Financial Results 33
Corporate Communications 35
Jul 03, 2017: Interleukin Genetics To Explore Strategic Alternatives, Reduce Workforce 35
Aug 03, 2016: Interleukin Genetics Strengthens Commercial Leadership with Key Appointments 36
Mar 16, 2016: Interleukin Genetics Appoints Global Clinical Advisory Board To Guide Enhanced Healthcare through Targeted Management of Systemic Inflammation 37
Product News 38
Nov 03, 2016: Interleukin Genetics Launches The ILUSTRA Inflammation Management Program 38
Other Significant Developments 39
Feb 23, 2017: Interleukin Genetics Deploys ILUSTRA Inflammation Management Program with mPulse Mobile Employees 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Interleukin Genetics Inc, Medical Equipment, Key Facts, 2016 2
Interleukin Genetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Interleukin Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Interleukin Genetics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Interleukin Genetics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Interleukin Genetics Inc, Deals By Market, 2011 to YTD 2017 8
Interleukin Genetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Interleukin Genetics Enters into Licensing Agreement with NYU School of Medicine 10
Interleukin Genetics Enters Into Research Collaboration With Metagenics 11
Access Business Group Enters into Licensing Agreement with Interleukin Genetics 12
Interleukin Genetics Raises USD5.6 Million in Private Placement of Shares 13
Interleukin Genetics Raises USD5 Million in Private Placement of Shares and Warrants 15
Interleukin Genetics Completes Private Placement Of Shares And Warrants For US$12 Million 16
Interleukin Genetics Completes Private Placement Of Series B Convertible Preferred Stock For US$3 Million 17
Interleukin Genetics Raises USD1 million in Issue of Subordinated Convertible Promissory Notes 18
Orig3N Acquires CLIA laboratory and Remaining Assets from Interleukin Genetics 19
Interleukin Genetics Inc, Key Competitors 20
Interleukin Genetics Inc, Key Employees 21

★海外企業調査レポート[Interleukin Genetics Inc (ILIU)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Safaricom Ltd:企業の戦略・SWOT・財務分析
    Safaricom Ltd - Strategy, SWOT and Corporate Finance Report Summary Safaricom Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Navidea Biopharmaceuticals Inc (NAVB):医療機器:M&Aディール及び事業提携情報
    Summary Navidea Biopharmaceuticals Inc (Navidea) is a biopharmaceutical company that develops precision immunodiagnostic agents and immunotherapeutics.. The company is focused on developing multiple precision-targeted products based on its Manocept platform to improve patient care. Its pipeline prod …
  • The Independent Order of Foresters:企業の戦略的SWOT分析
    The Independent Order of Foresters - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Johnson Electric Holdings Limited:企業の戦略・SWOT・財務情報
    Johnson Electric Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Johnson Electric Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Glow Energy Public Co Ltd (GLOW)-エネルギー分野:企業M&A・提携分析
    Summary Glow Energy Public Company Limited (Glow Energy), a subsidiary of Engie S.A., is an energy utility company. It generates and supplies electricity to Electricity Generating Authority of Thailand (EGAT). The company also generates and supplies electricity, steam, processed water and chilled wa …
  • The Hershey Co:戦略・SWOT・企業財務分析
    The Hershey Co - Strategy, SWOT and Corporate Finance Report Summary The Hershey Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Galilee Energy Ltd (GLL):石油・ガス:M&Aディール及び事業提携情報
    Summary Galilee Energy Ltd (Galilee) is a mining and minerals exploration and development company that offers exploration and development services. The company acquires, explores, produces, and develops coal seam gas in the Galilee Basin near Longreach in Queensland. It offers projects such as ATP79 …
  • Denbury Resources Inc.:企業の戦略・SWOT・財務分析
    Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Wartsila Corp (WRT1V):電力:M&Aディール及び事業提携情報
    Summary Wartsila Corp (Wartsila) is a mechanical or industrial engineering company. It offers smart technologies and complete lifecycle solutions. Through sustainable innovation, total efficiency, and data analytics, the company harnesses the environmental and economic performance of the vessels and …
  • The Prudential Insurance Company of America:企業のM&A・事業提携・投資動向
    The Prudential Insurance Company of America - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Prudential Insurance Company of America Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Physiomics Plc (PYC)-製薬・医療分野:企業M&A・提携分析
    Summary Physiomics plc (Physiomics) is a computational systems biology services company. It is involved in developing outsourced systems and computational systems biology models for predicting and understanding cancer drug efficacy from pre-clinical research to clinical development and finding optim …
  • TETRA Technologies Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    TETRA Technologies Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary TETRA Technologies Inc (TETRA) is an oil and gas company that offers completion fluids and associated products and services. The company’s services comprise compression services, fluid, filtration …
  • Japan Airlines Co Ltd:企業のM&A・事業提携・投資動向
    Japan Airlines Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Japan Airlines Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • NCI Building Systems, Inc. (NCS):企業の財務・戦略的SWOT分析
    NCI Building Systems, Inc. (NCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • HNB Assurance PLC (HASU.N0000):企業の財務・戦略的SWOT分析
    HNB Assurance PLC (HASU.N0000) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ipsen SA (IPN):企業の財務・戦略的SWOT分析
    Ipsen SA (IPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • MDU Resources Group Inc (MDU):企業の財務・戦略的SWOT分析
    MDU Resources Group Inc (MDU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Amathus Public Ltd:企業の戦略・SWOT・財務情報
    Amathus Public Ltd - Strategy, SWOT and Corporate Finance Report Summary Amathus Public Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • China Sunergy Co., Ltd.:電力:M&Aディール及び事業提携情報
    Summary China Sunergy Co., Ltd. (China Sunergy) is a leading manufacturer of solar cells and modules. It produces mono-crystalline and multi-crystalline silicon solar cells. The company offers standard P-type solar cells and HP solar cells; and selective emitter cells. China Sunergy also invests in, …
  • Magyar Nemzeti Bank:企業の戦略的SWOT分析
    Magyar Nemzeti Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆